Attached files
| file | filename |
|---|---|
| 8-K - 8-K - F-star Therapeutics, Inc. | d40312d8k.htm |
Exhibit 16.1
PricewaterhouseCoopers LLP
Cambridge, United Kingdom
www.pwc.com
April 5, 2021
Securities and Exchange Commission
100 F Street, N.E.
Washington, DC 20549
Commissioners:
We have read the statement made by F-star Therapeutics, Inc. (copy attached) which we understand will be filed with the Securities and Exchange Commission, pursuant to Item 4.01 of Form 8-K of F-star Therapeutics, Inc., dated March 31, 2021. We agree with the statements concerning our Firm contained therein.
| Very truly yours, | ||
| /s/ PricewaterhouseCoopers LLP | ||
| PricewaterhouseCoopers LLP | ||
| Cambridge, United Kingdom | ||